Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia

Published:2023-07-24 Issue: Volume:13 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Hu Chi-Hao,Wu Sheng-Nan,So Edmund Cheung

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference12 articles.

1. The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small lung cancer in Taiwan;Chang;Front Oncol,2023

2. Tyrosine kinase inhibitors – a review on pharmacology, metabolism and side effects;Hartmann;Curr Drug Metab,2009

3. Characterization of the synergistic inhibition of IK(erg) and IK(DR) by ribociclib, a cyclin-dependent kinase 4/6 inhibitor;Liu;Int J Mol Sci,2020

4. Simulation of the cardiac action potential based on the Hodgkin-Huxley kinetics with the use of Microsoft excel spreadsheets;Wu;Chin J Physiol,2004

5. Electrophysiological mechanism of ventricular arrhythmias in relation to Andersen-tawil syndrome under conditions of reduced IK1 simulation study;Sung;Am J Physiol Heart Circ Physiol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Derivatives of D(−) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis;European Journal of Medicinal Chemistry;2024-08

2. Assessing the Impact of Agents with Antiviral Activities on Transmembrane Ionic Currents: Exploring Possible Unintended Actions;Biophysica;2024-03-27

3. In-house glutamine based compound loaded poly-(D-L-lactide-coglycolide) nanoparticles as a possible candidate for the management of chronic myeloid leukemia;Materials Today: Proceedings;2023-11

4. Tyrosine Kinase Inhibitor Antitumor Therapy and Atrial Fibrillation: Potential Off-Target Effects on Mitochondrial Function and Cardiac Substrate Utilization;Cardiovascular Innovations and Applications;2023